Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Phosphorylation: new star of pathogenesis and treatment in steatotic liver disease ; volume:23 ; number:1 ; day:17 ; month:2 ; year:2024 ; pages:1-18 ; date:12.2024
Lipids in health and disease ; 23, Heft 1 (17.2.2024), 1-18, 12.2024
- Urheber
-
Lv, Tiansu
Lou, Yan
Yan, Qianhua
Nie, Lijuan
Cheng, Zhe
Zhou, Xiqiao
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12944-024-02037-9
- URN
-
urn:nbn:de:101:1-2404250829295.831975599291
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lv, Tiansu
- Lou, Yan
- Yan, Qianhua
- Nie, Lijuan
- Cheng, Zhe
- Zhou, Xiqiao
- SpringerLink (Online service)
Ähnliche Objekte (12)
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Integrating social nutrition principles into the treatment of steatotic liver disease
More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells
Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals
Astrocytes: Emerging stars in leukodystrophy pathogenesis
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency
Rapid deterioration of steatotic liver disease due to portal vein stenosis after pancreaticoduodenectomy
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Integrating social nutrition principles into the treatment of steatotic liver disease
More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells
Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals
Astrocytes: Emerging stars in leukodystrophy pathogenesis
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency
Rapid deterioration of steatotic liver disease due to portal vein stenosis after pancreaticoduodenectomy
Role of Glucocorticoids in Metabolic Dysfunction-Associated Steatotic Liver Disease
Integrating social nutrition principles into the treatment of steatotic liver disease
More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells
Fat causes necrosis and inflammation in parenchymal cells in human steatotic liver
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk: a comprehensive review
Opportunistic assessment of steatotic liver disease in lung cancer screening eligible individuals
Astrocytes: Emerging stars in leukodystrophy pathogenesis
Effects of semaglutide-loaded lipid nanocapsules on metabolic dysfunction-associated steatotic liver disease
Single‐cell transcriptomics stratifies organoid models of metabolic dysfunction‐associated steatotic liver disease
Steatotic liver disease associated with 2,4-dienoyl-CoA reductase 1 deficiency